Inflammation and Biopsy-site-marker in Breast Cancer (MOSAIC)
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY
The purpose of this study is to explore pro-metastatic changes in breast cancer (BC) associated with the stiffness of biopsy site markers. This study aims to determine whether the stiffness of a biopsy site marker promotes inflammatory changes in breast cancer and to evaluate whether there is a relationship between biopsy site marker stiffness and inflammation.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:
• Written informed consent (ICF) signed and dated by the patient prior to the performance of any study-specific procedures, sampling, or analyses.
• Female patients at \> 18 years of age at the time of signature of the ICF.
• Pathologically verified invasive breast cancer cases referred to OU for surgery.
Locations
United States
Oklahoma
OU Health Stephenson Cancer Center
RECRUITING
Oklahoma City
Contact Information
Primary
Lead Onco Nurse
SCC-IIT-Office@ouhsc.edu
405-271-8777
Backup
Takemi Tanaka, PhD
takemi-tanaka@ou.edu
Time Frame
Start Date: 2026-07-09
Estimated Completion Date: 2030-07
Participants
Target number of participants: 140
Treatments
Breast Cancer Patients
140 patients will be assigned to this group.
Related Therapeutic Areas
Sponsors
Leads: University of Oklahoma